Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children

Lancet

Volumn 351, Issue 9104, 1998, Pages 709-713

  Lell, Bertrand ^a,b   Luckner, Doris ^a,b   Ndjavé, Maryse ^a   Scott, Trevor ^c   Kremsner, Peter G ^a,b  

^a ALBERT SCHWEITZER HOSPITAL   (Gabon)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ATOVAQUONE; PROGUANIL;

ABDOMINAL PAIN; ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALARIA CONTROL; MALARIA FALCIPARUM; NAUSEA; ORAL DRUG ADMINISTRATION; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; VOMITING;

EID: 0032492438     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)09222-2     Document Type: Article

References (21)

1. 1 WHO. World malaria situation in 1994. Wkly Epidemiol Rec 1997; 72: 269-76.
2. 2 Menendez C, Kahigwa E, Hirt R, et al. Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants. Lancet 1997; 350: 844-50.
3. 3 Wolday D, Kibreab T, Bukenya D, Hodes R. Sensitivity of Plasmodium falciparum in vivo to chloroquine and pyrimethamine-sulfadoxine in Rwandan patients in a refugee camp in Zaire. Trans R Soc Trop Med Hyg 1995; 89: 654-56.
4. 4 Fry M, Pudney M. Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4′-chlorphenyl) cyclohexyl]-3-hydroxy-1,4-naphthoquinone(566C80). Biochem Pharmacol 1992; 43: 1545-53.
5. 5 Fawaz G, Haddad FS. The effect of lapinone (M-2350) on P vivax infection in man. Am J Trop Med 1951; 31: 569-71.
6. 6 Hughes W, Leoung G, Kramer F, et al. Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS. N Engl J Med 1993; 328: 1521-27.
7. 7 Torres RA, Weinberg W, Stansell J, et al. Atovaquone for salvage treatment and suppression of toxoplasmic encephalitis in patients with AIDS. Clin Infect Dis 1997; 24: 422-29.
8. 8 Looareesuwan S, Viravan C, Webster HK, Kyle DE, Hutchinson B, Canfield CJ. Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am J Trop Med Hyg 1996; 54: 62-66.
9. 9 Canfield CJ, Pudney M, Gutteridge WE. Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro. Exp Parasitol 1995; 80: 373-81.
10. 10 Fairley NH. Researches on paludrine (M4888) in malaria. Trans R Soc Trop Med Hyg 1946; 40: 105-62.
11. 11 Radloff PD, Philipps J, Nkeyi M, Hutchinson D, Kremsner PG. Atovaquone and proguanil for Plasmodium falciparum malaria. Lancet 1996; 347: 1511-14.
12. 12 Alencar FEC, Cerutti C, Durlacher RR, et al. Atovaquone and proguanil for the treatment of malaria in Brazil. J Infect Dis 1997; 175: 1544-47.
13. 13 Radloff PD, Philipps J, Hutchinson D, Kremsner PG. Atovaquone plus proguanil is an effective treatment for Plasmodium ovale and P malariae malaria. Trans R Soc Trop Med Hyg 1996; 90: 682.
14. 14 Wildling E, Winkler S, Kremsner PG, Brandts C, Jenne L, Wernsdorfer WH. Malaria epidemiology in the province of Moyen Ogooué, Gabon. Trop Med Parasitol 1995; 46: 77-82.
15. 15 Kremsner PG, Winkler S, Brandts C, Neifer S, Bienzle U, Graninger W. Clindamycin in combination with chloroquine or quinine is an effective therapy for uncomplicated P falciparum malaria in children from Gabon. J Infect Dis 1994; 169: 467-70.
16. 16 Kremsner PG, Zotter GM, Feldmeier H, Graninger W, Rocha RM, Wiedermann G. A comparative trial of three regimens for treating uncomplicated falciparum malaria in Acre, Brazil. J Infect Dis 1988; 158: 1368-71.
17. 17 Ederer F, Mantel N. Confidence limits on the ratio of two Poisson variables. Am J Epidemiol 1974; 100: 165-67.
18. 18 Hussein Z, Eaves J, Hutchinson DB, Canfield CJ. Population pharmacokinetics of atovaquone in patients with acute malaria caused by Plasmodium falciparum. Clin Pharmacol Ther 1997; 61: 518-30.
19. 19 Hussein Z, Eaves CJ, Hutchinson DB, Canfield CJ. Population pharmacokinetics of proguanil in patients with acute P falciparum malaria after combined therapy with atovaquone. Br J Clin Pharmacol 1996; 42: 589-97.
20. 20 Foege WH. Malarone-donation programme. Lancet 1997; 350: 1628-29.
21. 21 Bloland PB, Kazembe PN, Watkins WM, Doumbo OK, Nwanyanwu OC, Ruebush TK. Malarone-donation programme in Africa. Lancet 1997; 350: 1624-25.